Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ELOVL4 anticorps

ELOVL4 Reactivité: Humain WB Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN4620376
  • Antigène Voir toutes ELOVL4 Anticorps
    ELOVL4 (ELOVL Fatty Acid Elongase 4 (ELOVL4))
    Reactivité
    • 41
    • 15
    • 10
    • 5
    • 2
    • 2
    Humain
    Hôte
    • 41
    Lapin
    Clonalité
    • 41
    Polyclonal
    Conjugué
    • 18
    • 6
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp ELOVL4 est non-conjugé
    Application
    • 31
    • 28
    • 7
    • 4
    • 4
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Specificité
    This antibody detects ELOV4, expressed in the retina and at much lower level in the brain.
    Purification
    Affinity chromatography
    Immunogène
    Synthetic peptdide derived from the human ELOV4 protein
    Isotype
    IgG
    Top Product
    Discover our top product ELOVL4 Anticorps primaire
  • Indications d'application
    Western Blot (1: 400 starting dilution).
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Restrictions
    For Research Use only
  • Buffer
    Phosphate buffered saline with 0.08 % sodium azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Avoid repeated freezing and thawing.
    Stock
    -20 °C
    Stockage commentaire
    Store the product (in aliquots) at -20 °C. Can be shipped at 2 - 8 °C.
  • Antigène
    ELOVL4 (ELOVL Fatty Acid Elongase 4 (ELOVL4))
    Autre désignation
    ELOVL4 (ELOVL4 Produits)
    Synonymes
    anticorps elovl4, anticorps MGC122553, anticorps ADMD, anticorps CT118, anticorps ISQMR, anticorps STGD2, anticorps STGD3, anticorps elongation of very long chain fatty acids protein 4, anticorps ELOVL fatty acid elongase 4, anticorps elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4, anticorps CpipJ_CPIJ002114, anticorps CpipJ_CPIJ003687, anticorps CpipJ_CPIJ011025, anticorps CpipJ_CPIJ013819, anticorps ELOVL4, anticorps elovl4, anticorps Elovl4
    Sujet
    Mutations in elongation of very long-chain fatty acid-4 (ELOVL4) are associated with autosomal dominant Stargardt-like macular degeneration (STGD3), with a five base-pair (5 bp) deletion mutation resulting in the loss of 51 carboxy-terminal amino acids and truncation of the protein. Elovl4 is expressed in the retina and only a limited number of mammalian other tissues, including skin, with unknown function. In a mouse model with the 5-bp deletion in the Elovl4 gene, mice in the heterozygous state (Elovl4(+/del)) demonstrate progressive photoreceptor degeneration. Homozygous mice (Elovl4(del/del)) display scaly, wrinkled skin, have severely compromised epidermal permeability barrier function, and die within a few hours after birth. Lipid analyses of epidermis from Elovl4(del/del) mice show a decrease in very long-chain fatty acids (VLFAs) in both the ceramide/glucosylceramide and the free fatty-acid fractions. ELOVL4 is required for generating VLFA critical for epidermal barrier function.Synonyms: 3-keto acyl-CoA synthase ELOVL4, Elongation of very long chain fatty acids protein 4
    ID gène
    6785
    NCBI Accession
    NP_073563
    UniProt
    Q9GZR5
Vous êtes ici:
Support technique